organization · Reporting owner
HFCP VII (PARALLEL-A), L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PPD, Inc.
Report date December 08, 2021 · Filed December 08, 2021
Jointly reported with H&F Corporate Investors VII, Ltd., Hellman & Friedman Investors VII, L.P., HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P., HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P., H&F EXECUTIVES VII, L.P., Thorpe Allen R
Section 16 reporting ended · disclosed 2021-12-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-12-08 · Sale · Disposed 52,884,036 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F2: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-12-08 · Sale · Disposed 20,244,387 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F3: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2021-12-08 · Sale · Disposed 3,630,740 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F4: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2021-12-08 · Sale · Disposed 359,372 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F5: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2021-12-08 · Sale · Disposed 35,622,429 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F6: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2021-12-08 · Sale · Disposed 15,987,409 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F7: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2021-12-08 · Sale · Disposed 3,021,286 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F8: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2021-12-08 · Sale · Disposed 934,469 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F9: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2021-12-08 · Sale · Disposed 157,138 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F10: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash.
F2: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII").
F3: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel").
F4: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A").
F5: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds").
F6: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").
F7: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").
F8: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").
F9: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").
F10: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").
F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 157,138 | $47.50 | $7,464,055.00 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 9 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F10 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 934,469 | $47.50 | $44,387,277.50 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 8 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F9 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 3,021,286 | $47.50 | $143,511,085.00 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 7 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F8 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 15,987,409 | $47.50 | $759,401,927.50 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 6 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F7 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 35,622,429 | $47.50 | $1,692,065,377.50 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 5 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F6 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 359,372 | $47.50 | $17,070,170.00 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 4 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F5 · ownership.nature: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 3,630,740 | $47.50 | $172,460,150.00 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 3 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F4 · ownership.nature: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 20,244,387 | $47.50 | $961,608,382.50 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:53 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 52,884,036 | $47.50 | $2,511,991,710.00 |
DisclosureSEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | GiftCommon Stock | 127,867 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 11 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F13 · ownership.direct: These shares of Common Stock were received by Mr. Thorpe in connection with pro rata distributions made by HFCP VII described above and were transferred as a charitable donation upon receipt. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 30,264 | $31.28 | $946,733.58 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 10 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 157,138 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F10 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 179,980 | $31.28 | $5,630,224.35 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 9 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 934,469 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F9 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 581,903 | $31.28 | $18,203,380.60 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 8 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,021,286 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F8 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 3,079,193 | $31.28 | $96,324,855.02 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 7 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 15,987,409 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F7 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 6,860,919 | $31.28 | $214,626,698.62 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 6 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 35,622,429 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F6 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 69,215 | $31.28 | $2,165,218.24 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 5 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 359,372 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F5 · ownership.nature: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 699,284 | $31.28 | $21,875,351.73 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 4 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,630,740 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F4 · ownership.nature: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 3,899,092 | $31.28 | $121,973,345.49 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 3 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 20,244,387 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | OtherCommon Stock | 883,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 52,884,036 F12 · kind: Represents in-kind distributions of shares of Common Stock previously held by HFCP VII to certain of its direct and indirect partners for the sole purpose of charitable giving. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 16:47 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 9,302,325 | $31.28 | $290,999,981.81 |
DisclosureSEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 53,767,236 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.